BTN3A2 and ovarian carcinoma: Actually, as a crucial mediator in immune activation, butyrophilin subfamily 3 member A2 (BTN3A2) was widely investigated in cancer initiation and development, revealing a tight link between immune infiltration and cancer development, especially in breast cancer (BRCA) and ovarian cancer (OV) (28).